SUPERNUS PHARMACEUTICALS, INC. ($SUPN)
Filing Information
| Accession Number | 0001804567-26-000002 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 20, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
16,500
Total Value
$0.00
P&L
+inf% (+$788,040.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
SVP, Chief Tech. Ops. Officer | Employee Stock Option (Right to Buy) | Derivative | Feb 18, 2026 | Grant/Award | 13,500 | $0.00 | $0.00 | 13,500 | Direct | โ | View Details | |
SVP, Chief Tech. Ops. Officer | Restricted Stock Unit | Derivative | Feb 18, 2026 | Grant/Award | 3,000 | $0.00 | $0.00 | 3,000 | Direct | โ | View Details |